isolated from a total of 1.6 ϫ 10 6 colonies, two of which were only one and ten amino acids longer, respectively, than clone 39-374 and are not displayed ( Figure 1A) .
tained by screening a rat sciatic nerve cDNA library and tify the specific regions responsible for protein-protein interaction by monitoring ␤-gal activity. It was striking by 5Ј RACE (see Experimental Procedures and Figure  1A ) and the deduced amino acid sequence was identical that all of the DRP2 clones from the two-hybrid screen included spectrin-like repeats and at least part of the to that recently reported with the exception of the following four changes: K525Q, R642K, H928L, and S929C adjacent WW domain, both of which are conserved in dystrophin and the dystrophin-related proteins (Figure (Roberts and Sheng, 2000) . To confirm that both L-periaxin and DRP2 are required to activate GAL4 transcrip-1A; for review see Winder, 1997) . Consistent with these observations, the minimal region required for interaction tion, we established that transformation of yeast cells with L-periaxin and DRP2 cDNAs was necessary both with L-periaxin comprised the two spectrin-like repeats of the DRP polypeptide ( Figure 1B) . The WW domain for ␤-galactosidase (␤-gal) activity and for growth of colonies on plates lacking histidine.
was not essential, although there was some attenuation in the strength of interaction with L-periaxin when this Truncation of DRP2 and L-periaxin allowed us to iden-region was truncated ( Figure 1B) . In order to determine DRP2 protein was very low in these tissues by compariif the binding of L-periaxin were specific for DRP2, we son with myelinated peripheral nerve ( Figure 3A) . Westcompared this interaction in a yeast two-hybrid assay ern blotting with an antibody raised against a different with the ability of L-periaxin to associate with the analo-DRP2 peptide gave identical results (data not shown Figure 3B ). Note that utrophin is also expressed in the well to DRP2 ( Figure 1C ). These ten amino acids include perineurium (arrow). the four contiguous lysines of BD1. BD1 has also been Thus, the results of yeast two-hybrid experiments, shown to be essential for NLS function (Sherman and biochemical studies, and immunolocalization analysis Brophy, 2000). Indeed, BD1 has substantial NLS activity converge to the conclusion that L-periaxin and DRP2 on its own (Sherman and Brophy, 2000) , in contrast to are present in a complex that is primarily expressed in its complete inability to bind DRP2 ( Figure 1C . We found that this In order to confirm that the interaction between L-periwas also the case for DRP2 ( Figure 4A ). Hence, it apaxin and DRP2 is physiologically relevant, we examined peared that DRP2 localizes to the Schwann cell plasma the subcellular and tissue distribution of DRP2. As has membrane by virtue of its binding to ␤-dystroglycan. been previously documented, L-periaxin was abunBecause L-periaxin interacts with DRP2, we then atdantly expressed in the Schwann cell plasma membrane tempted to isolate the L-periaxin complex from periph- ( Biochemical evidence for the ability of L-periaxin to dimerize was obtained by means of a "pull-down" assay. A GST-fusion protein that included the same region of L-periaxin as was used in the two-hybrid screen was able to bind intact L-periaxin in a sciatic nerve lysate ( Figure 6B ). In support of the two-hybrid data, truncation of the N terminus of L-periaxin to the core PDZ domain attenuated homodimerization with the full-length protein to a point where it was no longer detectable by affinity chromatography ( Figure 6B ). To confirm that full-length L-periaxin could homodimerize in a cellular environment, we showed that myc-tagged periaxin could be coimmuneprecipitated with FLAG-tagged periaxin when both were expressed in COS cells ( Figure 6C ). These results point to the ability of L-periaxin to cross-link DRP2-dystroglycan complexes in the submembranous cortex of the Schwann cell by virtue of its ability to homodimerize and account for the loss of DRP2 clustering in the peripheral nerves of Prx Ϫ/Ϫ mice. A model for the DRP2 complex is presented in Figure 7 .
Discussion
We have identified a peripheral demyelinating neuropathy in which a specific dystrophin-related protein complex is disrupted by the loss of L-periaxin. A central feature of this macromolecular structure is the importance of L-periaxin to the stability of the complex through its interaction with the dystrophin-related protein, DRP2. This interaction is specific in that L-periaxin does not associate directly with either of the other two members of the dystrophin family found in Schwann cells, namely dystrophin (Dp116) and utrophin, which suggests that these proteins are members of distinct dystroglycan complexes. This conclusion is supported by the fact that neither utrophin nor DRP2 can functionally substitute for Dp116 in the peripheral nerves of pa- between the PDZ domains of neuronal nitric oxide synthase (nNOS) and syntrophin has been shown to be a consequence of the interaction of the canonical peptide .5], 100 mM NaCl, 1 mM was mated with the prey in strain Y190. The full-length DRP2 cDNA was obtained by screening a random-primed P10 rat sciatic nerve EDTA, 0.5% NP40, 1 mM DTT, 1 mM PMSF, 5 g/ml leupeptin, 2 g/ml pepstatin, 0.5 mM TLCK). The washed beads were incubated library generated in gt11 using a 217 bp PCR fragment corresponding to amino acids 734-805 and by 5Ј RACE using the GeneRacer with the 35 S-labeled translation product (1 ϫ 10 6 cpm) in binding buffer for 1.5 hr at 4ЊC. The beads were washed extensively in Kit (Invitrogen). Deletion constructs of L-periaxin, S-periaxin, DRP2 and the C terminus of ␤-dystroglycan were generated by PCR and binding buffer before solubilization in SDS-PAGE sample buffer. Proteins were resolved in a 12% SDS-PAGE gel, Coomasie stained subcloned into either pAS2-1 to produce GAL4 binding domain fusions or pACT2 to produce GAL4 activation domain fusions. PCR to confirm equivalent fusion protein loading and processed for fluorography using Amplify (Amersham Pharmacia Biotech). For sciatic mutagenesis was performed using a Quikchange site-directed mutagenesis kit (Stratagene). The mutations were subsequently connerve pull-down assays, the perineurial sheaths of P16 or P21 rat sciatic nerves were removed, following which they were homogefirmed by sequencing. The PDZ domain mutation was generated by replacing glycine and phenylalanine at aa 31 and 32 of L-periaxin nized on ice in 25 mM Tris HCl (pH 7.5), 150 mM NaCl, 0.5% CHAPS, 50 mM NaF, 1 mM EDTA, 1 mM EGTA, 10 g/ml leupeptin, 10 with alanines. pACT-Dp116 (aa 86-379) and pACT-utrophin (aa 2552-2848) were obtained by reverse transcription (RT) PCR using g/ml antipain, 0.5 mM TLCK, 0.7 g/ml chymostatin, 10 g/ml benzamidine, 1 mM PMSF. The homogenate was centrifuged for 20 P10 and P12 mouse sciatic nerve RNA as template. The interactions were performed by cotransformation in Y190 or by yeast mating min at 13,000 g and the lysates were precleared by incubation for 45 min at 4ЊC with 25 l Glutathione-Sepharose beads. The cleared and assayed for reporter gene expression. ␤-galactosidase activity by filter lift assay was scored semiquantitatively by the time taken lysate was then incubated for 45 min at room temperature with GST fusion protein bound to beads. The beads were washed five times phate buffer containing 3% sucrose (pH 7.4) and processed for immunoelectron microscopy as described (Gillespie et al., 1994) . with lysis buffer, proteins were eluted with SDS-PAGE sample buffer, resolved on 8% SDS polyacrylamide gels, transferred to nitrocellulose, and analyzed by Western blotting using anti-170pep1
